{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:06:01Z","timestamp":1787673961308,"version":"build-2784847793"},"reference-count":210,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.resinv.2024.07.005","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:29:11Z","timestamp":1721208551000},"page":"817-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["What diagnostic tests are available for respiratory infections or pulmonary exacerbations in cystic fibrosis: A scoping literature review"],"prefix":"10.1016","volume":"62","author":[{"given":"Raasti","family":"Naseem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-8314","authenticated-orcid":false,"given":"Nicola","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-711X","authenticated-orcid":false,"given":"Sara","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4777-5458","authenticated-orcid":false,"given":"Kile","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.07.005_bib1","first-page":"878","article-title":"Metabolomic biomarkers to predict and diagnose cystic fibrosis pulmonary exacerbations: a systematic review","volume":"0","author":"Nguyen","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.resinv.2024.07.005_bib2","doi-asserted-by":"crossref","unstructured":"Bhatt JM. Treatment of pulmonary exacerbations in cystic fibrosis n.d. https:\/\/doi.org\/10.1183\/09059180.00006512.","DOI":"10.1183\/09059180.00006512"},{"key":"10.1016\/j.resinv.2024.07.005_bib4","series-title":"UK cystic fibrosis Registry 2021 Annual data report","year":"2022"},{"key":"10.1016\/j.resinv.2024.07.005_bib5","doi-asserted-by":"crossref","unstructured":"Stanford GE, Dave K, Simmonds NJ. Pulmonary Exacerbations in Adults With Cystic Fibrosis A Grown-up Issue in a Changing Cystic Fibrosis Landscape n.d. https:\/\/doi.org\/10.1016\/j.chest.2020.09.084.","DOI":"10.1016\/j.chest.2020.09.084"},{"key":"10.1016\/j.resinv.2024.07.005_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis \u00b7 1: epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.07.005_bib7","first-page":"19","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Socio Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.resinv.2024.07.005_bib10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/ppul.23781","article-title":"Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis","volume":"52","author":"Barsky","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0039-1698464","article-title":"Microbiology of cystic fibrosis airway disease","volume":"40","author":"Blanchard","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib12","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/j.jcf.2021.10.001","article-title":"Unexpected associations between respiratory viruses and bacteria with Pulmonary Function Testing in children suffering from Cystic Fibrosis (MUCOVIB study)","volume":"21","author":"Scherz","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1378\/chest.13-0693","article-title":"Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations","volume":"144","author":"Shoki","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.005_bib14","first-page":"637","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs","year":"1994"},{"key":"10.1016\/j.resinv.2024.07.005_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1513\/AnnalsATS.201211-107OC","article-title":"Changes in cystic fibrosis airway microbiota at pulmonary exacerbation","volume":"10","author":"Carmody","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2024.07.005_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00507-2020","article-title":"SPLUNC1: a novel marker of cystic fibrosis exacerbations","volume":"58","author":"Khanal","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5472\/marumj.1114952","article-title":"The role of procalcitonin as a biomarker for acute pulmonary exacerbation in subjects with cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"35","author":"Mammadov","year":"2022","journal-title":"Marmara Med. J."},{"key":"10.1016\/j.resinv.2024.07.005_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211070133","article-title":"A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis","volume":"16","author":"Nash","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/17476348.2015.1016504","article-title":"Management of pulmonary exacerbations in cystic fibrosis: still an unmet medical need in clinical practice","volume":"9","author":"Justicia","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2013-204000","article-title":"Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis","volume":"69","author":"Flight","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.07.005_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/00365548.2012.708942","article-title":"Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients","volume":"45","author":"Hoek","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cll.2014.02.001","article-title":"Infections in patients with cystic fibrosis: diagnostic microbiology update","volume":"34","author":"Gilligan","year":"2014","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/ped.2015.0509","article-title":"Pulmonary exacerbation score in cystic fibrosis patients: reliability and validity testing","volume":"28","author":"Keller","year":"2015","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40168-015-0074-9","article-title":"The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation","volume":"3","author":"Carmody","year":"2015","journal-title":"Microbiome"},{"key":"10.1016\/j.resinv.2024.07.005_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpam.2019.09.003","article-title":"The prevalence of viral infections in children with cystic fibrosis in a tertiary care center in Saudi Arabia","volume":"7","author":"Banjar","year":"2020","journal-title":"Int J Pediatr Adolesc Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12890-017-0366-x","article-title":"A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF): protocol for a randomised controlled trial","volume":"17","author":"Choyce","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/s17061245","article-title":"Smartphone-based pH sensor for home monitoring of pulmonary exacerbations in cystic fibrosis","volume":"17","author":"Sun","year":"2017","journal-title":"Sensors"},{"key":"10.1016\/j.resinv.2024.07.005_bib28","first-page":"S51","article-title":"Reevaluating approaches to cystic fibrosis pulmonary exacerbations","volume":"53","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/thoraxjnl-2019-213233","article-title":"Using digital technology for home monitoring, adherence and self-management in cystic fibrosis: a state-of-the-art review","volume":"75","author":"Calthorpe","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.07.005_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.896439","article-title":"Metabolomic biomarkers to predict and diagnose cystic fibrosis pulmonary exacerbations: a systematic review","volume":"10","author":"Nguyen","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.resinv.2024.07.005_bib31","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/ppul.23243","article-title":"Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection","volume":"50","author":"Caverly","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib32","first-page":"213","article-title":"Biomarkers in paediatric cystic fibrosis lung disease","volume":"16","author":"Ramsey","year":"2015","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.resinv.2024.07.005_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/archdischild-2012-302855","article-title":"The efficacy of cough plates in the identification of bacterial pathogens in children with cystic fibrosis","volume":"98","author":"Byrne","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.resinv.2024.07.005_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-015-0113-0","article-title":"A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa","volume":"15","author":"Linnane","year":"2015","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib35","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/jmv.24794","article-title":"Association of rhinovirus with exacerbations in young children affected by cystic fibrosis: preliminary data","volume":"89","author":"Stelzer-Braid","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.resinv.2024.07.005_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11046-017-0150-8","article-title":"Challenges in laboratory detection of fungal pathogens in the airways of cystic fibrosis patients","volume":"183","author":"Chen","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.resinv.2024.07.005_bib37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcf.2020.09.003","article-title":"Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: a pilot study","volume":"20","author":"Cardot-Martin","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx069","article-title":"Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis","volume":"75","author":"Mauch","year":"2017","journal-title":"Pathog Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcf.2016.10.005","article-title":"Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study","volume":"16","author":"Barr","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-2600(18)30171-1","article-title":"The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial","volume":"6","author":"Ronchetti","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib41","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.chest.2020.06.044","article-title":"BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis","volume":"158","author":"Ishak","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.005_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00408-017-0024-3","article-title":"Clinically promising biomarkers in cystic fibrosis pulmonary exacerbations","volume":"195","author":"Scott","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2024.07.005_bib43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10096-014-2286-5","article-title":"A rapid method for breath analysis in cystic fibrosis patients","volume":"34","author":"Kramer","year":"2015","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cct.2013.09.004","article-title":"Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial","volume":"36","author":"Lechtzin","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.resinv.2024.07.005_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jcf.2014.03.003","article-title":"Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful?","volume":"13","author":"Wilson","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12890-016-0327-9","article-title":"Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis","volume":"16","author":"Kotnik Pirs","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"Suppl 3","key":"10.1016\/j.resinv.2024.07.005_bib47","first-page":"S18","article-title":"Improving outcomes of infections in cystic fibrosis in the era of CFTR modulator therapy","volume":"54","author":"Saiman","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1183\/09031936.00225214","article-title":"Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis","volume":"46","author":"Barr","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcf.2013.04.007","article-title":"Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients","volume":"12","author":"Fothergill","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2013.02.003","article-title":"What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis?","volume":"12","author":"Liu","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-201360","article-title":"Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis","author":"Mosquera","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.resinv.2024.07.005_bib52","first-page":"50","article-title":"The role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis","volume":"55","author":"Dogru","year":"2013","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.resinv.2024.07.005_bib53","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1378\/chest.12-1363","article-title":"IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis","volume":"143","author":"Baxter","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.005_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13000-014-0158-z","article-title":"Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA)","volume":"9","author":"Mauch","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.resinv.2024.07.005_bib55","first-page":"26","article-title":"Phenotypic and genetic characterization of carbapenemase and ESBLs producing gram-negative bacteria (GNB) isolated from patients with cystic fibrosis in Tehran hospitals","volume":"8","author":"Vali","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089341","article-title":"Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis","volume":"9","author":"Quon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/archdischild-2012-303408","article-title":"How to use: bacterial cultures in diagnosing lower respiratory tract infections in cystic fibrosis","volume":"99","author":"Ahmed","year":"2014","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.resinv.2024.07.005_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1164\/rccm.201404-0681OC","article-title":"Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes","volume":"190","author":"Mayer-Hamblett","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jcf.2013.05.013","article-title":"Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children","volume":"13","author":"Blau","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib60","first-page":"B36","article-title":"Comparative analysis of real time PCR and ELISA for the detection of pseudomonas aeruginosa in not chronically infected cystic fibrosis patients","volume":"5","author":"Khodabakhshi","year":"2014","journal-title":"Int J Pharma Bio Sci"},{"key":"10.1016\/j.resinv.2024.07.005_bib61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcf.2013.12.007","article-title":"Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis","volume":"13","author":"Kondori","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115584","article-title":"Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections","volume":"9","author":"Joensen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib63","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ppul.22917","article-title":"Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis","volume":"49","author":"Esther","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib64","first-page":"179","article-title":"Modified culture method detects a high diversity of fungal species in cystic fibrosis patients","volume":"52","author":"Masoud-Landgraf","year":"2014","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2024.07.005_bib65","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1002\/ppul.23101","article-title":"Mycobacterium avium complex (MAC) presenting as the first infection in a child with cystic fibrosis","volume":"50","author":"Colin","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib66","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ppul.23150","article-title":"Sputum induction improves detection of pathogens in children with cystic fibrosis","volume":"50","author":"Hoppe","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib67","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcf.2014.10.002","article-title":"Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis","volume":"14","author":"Laguna","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.14-1800","article-title":"Metabolomic evaluation of neutrophilic airway inflammation in cystic fibrosis","volume":"148","author":"Esther","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.005_bib69","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1183\/09031936.00011815","article-title":"Serodiagnosis of mycobacterium abscessus complex infection in cystic fibrosis","volume":"46","author":"Qvist","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0035-1546751","article-title":"Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"36","author":"Park","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib71","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/JCM.00432-15","article-title":"Rapid detection of emerging pathogens and loss of microbial diversity associated with severe lung disease in cystic fibrosis","volume":"53","author":"Flight","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib72","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/JCM.00368-15","article-title":"Pseudomonas aeruginosa and periodontal pathogens in the oral cavity and lungs of cystic fibrosis patients: a case-control study","volume":"53","author":"Caldas","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib73","first-page":"CD009530","article-title":"Bronchoscopy-guided antimicrobial therapy for cystic fibrosis","volume":"1","author":"Jain","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resinv.2024.07.005_bib74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1164\/rccm.201509-1759OC","article-title":"Development of the nasopharyngeal microbiota in infants with cystic fibrosis","volume":"193","author":"Prevaes","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164232","article-title":"Throat swabs and sputum culture as predictors of P. aeruginosa or S. aureus lung colonization in adult cystic fibrosis patients","volume":"11","author":"Seidler","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajic.2015.08.023","article-title":"Infection control strategies that successfully controlled an outbreak of Mycobacterium abscessus at a cystic fibrosis center","volume":"44","author":"Kapnadak","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.resinv.2024.07.005_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1183\/13993003.01068-2015","article-title":"Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"47","author":"Gernez","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2015-207983","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.07.005_bib79","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pcl.2016.04.003","article-title":"Cystic fibrosis: microbiology and host response","volume":"63","author":"Zemanick","year":"2016","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.resinv.2024.07.005_bib80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17476348.2016.1177460","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches","volume":"10","author":"Lund-Palau","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib81","first-page":"203","article-title":"Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study","volume":"23","author":"Hery-Arnaud","year":"2017","journal-title":"CMI"},{"key":"10.1016\/j.resinv.2024.07.005_bib82","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/apm.12689","article-title":"Diagnosis of biofilm infections in cystic fibrosis patients","volume":"125","author":"Hoiby","year":"2017","journal-title":"APMIS"},{"key":"10.1016\/j.resinv.2024.07.005_bib83","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcf.2016.06.007","article-title":"Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients","volume":"16","author":"Wettlaufer","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib84","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cix203","article-title":"Cystic fibrosis pulmonary exacerbations attributable to respiratory syncytial virus and influenza: a population-based study","volume":"64","author":"Somayaji","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib85","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00832-2017","article-title":"Airway microbiota across age and disease spectrum in cystic fibrosis","volume":"50","author":"Zemanick","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2016.11.004","article-title":"Multiplex PCR reveals that viruses are more frequent than bacteria in children with cystic fibrosis","volume":"86","author":"Miro-Canis","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.resinv.2024.07.005_bib87","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1513\/AnnalsATS.201611-935OC","article-title":"Multiple-breath washout outcomes are sensitive to inflammation and infection in children with cystic fibrosis","volume":"14","author":"Ramsey","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2024.07.005_bib88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17476348.2017.1288102","article-title":"The diagnosis and management of respiratory viral infections in cystic fibrosis","volume":"11","author":"Flight","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib89","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcf.2017.10.016","article-title":"Pooling of bronchoalveolar lavage in children with cystic fibrosis does not adversely affect the microbiological yield or sensitivity in detecting pulmonary inflammation","volume":"17","author":"McNally","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11046-017-0199-4","article-title":"Invasive pulmonary fungal infections in cystic fibrosis","volume":"183","author":"Schwarz","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.resinv.2024.07.005_bib91","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/crj.12703","article-title":"Procalcitonin, erythrocyte sedimentation rate and C-reactive protein in acute pulmonary exacerbations of cystic fibrosis","volume":"12","author":"Loh","year":"2018","journal-title":"Clin. Respir. J"},{"key":"10.1016\/j.resinv.2024.07.005_bib92","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10096-017-3168-4","article-title":"Understanding Pseudomonas status among adults with cystic fibrosis: a real-world comparison of the Leeds criteria against clinicians' decision","volume":"37","author":"Hoo","year":"2018","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib93","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/apm.12903","article-title":"The importance of early diagnosis of Mycobacterium abscessus complex in patients with cystic fibrosis","volume":"126","author":"Ravnholt","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.resinv.2024.07.005_bib94","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/mmy\/myx106","article-title":"Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis","volume":"56","author":"Schwarz","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2024.07.005_bib95","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1186\/s12879-018-3612-9","article-title":"Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study","volume":"18","author":"Mangiaterra","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12890-018-0668-7","article-title":"Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis","volume":"18","author":"Hovold","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib97","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00238-2018","article-title":"The clinical significance of oropharyngeal cultures in young children with cystic fibrosis","volume":"51","author":"Breuer","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib98","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1002\/ppul.24126","article-title":"The myriad challenges of respiratory fungal infection in cystic fibrosis","volume":"53","author":"Tracy","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00365-18","article-title":"Refining the application of microbial lipids as tracers of Staphylococcus aureus growth rates in cystic fibrosis sputum","volume":"200","author":"Neubauer","year":"2018","journal-title":"J Bacteriol"},{"key":"10.1016\/j.resinv.2024.07.005_bib100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jcf.2018.05.015","article-title":"Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis","volume":"17","author":"Hoppe","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib101","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41598-017-18491-8","article-title":"Volatile molecules from bronchoalveolar lavage fluid can \u201crule-in\u201d Pseudomonas aeruginosa and \u201crule-out\u201d Staphylococcus aureus infections in cystic fibrosis patients","volume":"8","author":"Nasir","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.07.005_bib102","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12874-019-0705-0","article-title":"Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis","volume":"19","author":"Liou","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.resinv.2024.07.005_bib103","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01771-2018","article-title":"The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis","volume":"54","author":"Rosenow","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib104","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3201\/eid2503.181590","article-title":"Mycobacterium chimaera pulmonary disease in cystic fibrosis patients, France, 2010-2017","volume":"25","author":"Larcher","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jcf.2019.04.013","article-title":"The role of geographical location and climate on recurrent Pseudomonas infection in young children with Cystic Fibrosis","volume":"18","author":"Warrier","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib106","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jcf.2018.05.014","article-title":"RNA sequencing data from neutrophils of patients with cystic fibrosis reveals potential for developing biomarkers for pulmonary exacerbations","volume":"18","author":"Jiang","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rmed.2019.04.012","article-title":"The role of microRNAs in chronic pseudomonas lung infection in Cystic fibrosis","volume":"151","author":"Fesen","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib108","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/ciz069","article-title":"Children with cystic fibrosis are infected with multiple subpopulations of Mycobacterium abscessus with different antimicrobial resistance profiles","volume":"69","author":"Shaw","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/mmy\/myy014","article-title":"The diagnosis and management of respiratory tract fungal infection in cystic fibrosis: a UK survey of current practice","volume":"57","author":"Boyle","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2024.07.005_bib110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/21678707.2020.1713748","article-title":"Gram negative infections in cystic fibrosis: a review of preventative and treatment options","volume":"8","author":"Addy","year":"2020","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.resinv.2024.07.005_bib111","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jcf.2020.02.013","article-title":"Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers","volume":"19","author":"Low","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106103","article-title":"A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosis","volume":"171","author":"Hoo","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.582964","article-title":"Current approach in the diagnosis and management of allergic bronchopulmonary aspergillosis in children with cystic fibrosis","volume":"8","author":"Sunman","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.resinv.2024.07.005_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104478","article-title":"The role of rhinovirus infections in young children with cystic fibrosis","volume":"129","author":"O Loughlin","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.resinv.2024.07.005_bib115","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41598-020-63970-0","article-title":"Cell free DNA from respiratory pathogens is detectable in the blood plasma of Cystic Fibrosis patients","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.07.005_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240452","article-title":"Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis","volume":"15","author":"Meyer","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib117","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11046-021-00574-w","article-title":"Emerging fungal threats in cystic fibrosis","volume":"186","author":"Schwarz","year":"2021","journal-title":"Mycopathologia"},{"key":"10.1016\/j.resinv.2024.07.005_bib118","article-title":"Prospective evaluation of Aspergillus fumigatus-specific IgG in patients with cystic fibrosis","volume":"10","author":"Eschenhagen","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens9090716","article-title":"Allergic bronchopulmonary aspergillosis in children with cystic fibrosis: an update on the newest diagnostic tools and therapeutic approaches","volume":"9","author":"Lattanzi","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.resinv.2024.07.005_bib120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00330-020-07095-y","article-title":"Predictive value of the modified Bhalla score for assessment of pulmonary exacerbations in adults with cystic fibrosis","volume":"31","author":"Diab-Caceres","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib121","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2147\/IDR.S267219","article-title":"Managing fungal infections in cystic fibrosis patients: challenges in clinical practice","volume":"14","author":"Magee","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.resinv.2024.07.005_bib122","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/pathogens10050618","article-title":"Fungal infection and inflammation in cystic fibrosis","volume":"10","author":"Poore","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.resinv.2024.07.005_bib123","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa074","article-title":"Chlamydia pneumoniae and Mycoplasma pneumoniae in children with cystic fibrosis: impact on bacterial respiratory microbiota diversity","volume":"79","author":"Pittet","year":"2021","journal-title":"Pathog Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib124","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/mmy\/myab010","article-title":"Pneumocystis jirovecii among patients with cystic fibrosis and their household members","volume":"59","author":"Morilla","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2024.07.005_bib125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41390-021-01419-4","article-title":"Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids","volume":"90","author":"Felton","year":"2021","journal-title":"Pediatr Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib126","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2024.07.005_bib127","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1183\/23120541.00578-2020","article-title":"Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection","volume":"7","author":"Caverly","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/17476348.2021.1908131","article-title":"A multimodal approach to detect and monitor early lung disease in cystic fibrosis","volume":"15","author":"Mondejar-Lopez","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib129","article-title":"Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?","volume":"30","author":"Lv","year":"2021","journal-title":"ERR"},{"key":"10.1016\/j.resinv.2024.07.005_bib130","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.3390\/jcm10214884","article-title":"Lung clearance index in children with cystic fibrosis during pulmonary exacerbation","volume":"10","author":"Walicka-Serzysko","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib131","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/archdischild-2021-322177","article-title":"Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study","volume":"107","author":"Saint","year":"2022","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.resinv.2024.07.005_bib132","article-title":"Network analysis to identify multi-omic correlations in the lower airways of children with cystic fibrosis","volume":"12","author":"O'Connor","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib133","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jhmas\/jrab056","article-title":"Diagnostic uncertainty, microbes, and the isolation of people with cystic fibrosis","volume":"77","author":"Labonte","year":"2022","journal-title":"J Hist Med Allied Sci"},{"issue":"10","key":"10.1016\/j.resinv.2024.07.005_bib134","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/ppul.26040","article-title":"Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics","volume":"57","author":"Huang","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib135","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ac6bb6","article-title":"Breath biomarkers associated with nontuberculosis mycobacteria disease status in persons with cystic fibrosis: a pilot study","volume":"16","author":"Mani-Varnosfaderani","year":"2022","journal-title":"J Breath Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib136","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/diagnostics12071514","article-title":"Nontuberculous mycobacterial lung disease in the patients with cystic fibrosis-A challenging diagnostic problem","volume":"12","author":"Wyrostkiewicz","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.resinv.2024.07.005_bib137","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/ppul.25925","article-title":"Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis","volume":"57","author":"Bouzek","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib138","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.chest.2022.02.007","article-title":"Managing pulmonary infection in adults with cystic fibrosis: adult cystic fibrosis series","volume":"162","author":"Green","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.005_bib139","doi-asserted-by":"crossref","first-page":"549","DOI":"10.24953\/turkjped.2020.1926","article-title":"Is there a role of viral infection in cystic fibrosis exacerbation in children?","volume":"64","author":"Hamed","year":"2022","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.resinv.2024.07.005_bib140","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00192-22","article-title":"IgA serological response for the diagnosis of Mycobacterium abscessus infections in patients with cystic fibrosis","volume":"10","author":"le Moigne","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.resinv.2024.07.005_bib141","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ac8369","article-title":"Non-invasive diagnostics of pathogenic bacteria using a breath sampler in children with cystic fibrosis","volume":"16","author":"van Aerde","year":"2022","journal-title":"J Breath Res."},{"issue":"7","key":"10.1016\/j.resinv.2024.07.005_bib142","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/17476348.2022.2104249","article-title":"The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosis","volume":"16","author":"Barucha","year":"2022","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib143","first-page":"28","article-title":"Detecting respiratory infection in children with cystic fibrosis: cough swab, sputum induction or bronchoalveolar lavage","volume":"31","author":"Forton","year":"2019","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.resinv.2024.07.005_bib144","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcf.2019.02.004","article-title":"Early respiratory viral infections in infants with cystic fibrosis","volume":"18","author":"Deschamp","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226578","article-title":"Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline","volume":"14","author":"Glasser","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib146","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4187\/respcare.06697","article-title":"Cystic fibrosis lung disease: an overview","volume":"65","author":"Turcios","year":"2020","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.resinv.2024.07.005_bib147","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcf.2022.06.007","article-title":"Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosis","volume":"22","author":"Perrem","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib148","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MCP.0000000000000732","article-title":"Monitoring early stage lung disease in cystic fibrosis","volume":"26","author":"Nissenbaum","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib149","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.riam.2019.10.004","article-title":"Taking a look on fungi in cystic fibrosis: more questions than answers","volume":"37","author":"Mart\u00edn-G\u00f3mez","year":"2020","journal-title":"Rev Iberoam De Micol"},{"key":"10.1016\/j.resinv.2024.07.005_bib150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5507\/bp.2016.050","article-title":"McRAPD unlike MALDI-TOF MS is a suitable candidate for routine discrimination of new Haemophilus influenzae strain acquisition in chronic obstructive pulmonary disease (COPD) and cystic fibrosis","volume":"160","author":"Raclavsky","year":"2016","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.resinv.2024.07.005_bib151","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/09674845.2013.11669948","article-title":"Matrix-assisted laser desorption\/ionisation-time of flight mass spectrometry: rapid identification of bacteria isolated from patients with cystic fibrosis","volume":"70","author":"Baillie","year":"2013","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.resinv.2024.07.005_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153876","article-title":"Culture-independent identification of nontuberculous mycobacteria in cystic fibrosis respiratory samples","volume":"11","author":"Caverly","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib153","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/10\/4\/047103","article-title":"Bacteria in the airways of patients with cystic fibrosis are genetically capable of producing VOCs in breath","volume":"10","author":"Bos","year":"2016","journal-title":"J Breath Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib154","doi-asserted-by":"crossref","DOI":"10.5812\/pedinfect.64834","article-title":"Molecular identification of gram-negative bacteria in respiratory samples of cystic fibrosis patients from a children referral hospital in Tehran","volume":"7","author":"Azimi","year":"2019","journal-title":"Arch Pediatr Infect Dis"},{"issue":"6","key":"10.1016\/j.resinv.2024.07.005_bib155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jcf.2022.01.006","article-title":"The lung microbiota in children with cystic fibrosis captured by induced sputum sampling","volume":"21","author":"Weiser","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib156","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2049-2618-2-40","article-title":"Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis","volume":"2","author":"Willger","year":"2014","journal-title":"Microbiome"},{"key":"10.1016\/j.resinv.2024.07.005_bib157","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcf.2017.12.007","article-title":"One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosis","volume":"17","author":"Boutin","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib158","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/9\/2\/027104","article-title":"Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis","volume":"9","author":"Shestivska","year":"2015","journal-title":"J Breath Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib159","first-page":"1","article-title":"Pseudomonas aeruginosa volatilome characteristics and adaptations in chronic cystic fibrosis lung infections","volume":"5","author":"Bhebhe","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.resinv.2024.07.005_bib160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcf.2016.10.012","article-title":"Oxidized glutathione and uric acid as biomarkers of early cystic fibrosis lung disease","volume":"16","author":"Dickerhof","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib161","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jcf.2021.08.030","article-title":"Novel detection of specific bacterial quorum sensing molecules in saliva: potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis","volume":"21","author":"Webb","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib162","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1039\/C4AN00675E","article-title":"Electrochemistry provides a point-of-care approach for the marker indicative of Pseudomonas aeruginosa infection of cystic fibrosis patients","volume":"139","author":"Metters","year":"2014","journal-title":"Analyst"},{"key":"10.1016\/j.resinv.2024.07.005_bib163","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2500\/ajra.2017.31.4422","article-title":"Respiratory viral detection in the paranasal sinuses of patients with cystic fibrosis","volume":"31","author":"Rowan","year":"2017","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.resinv.2024.07.005_bib164","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jpids\/pit039","article-title":"Home self-collection of nasal swabs for diagnosis of acute respiratory virus infections in children with cystic fibrosis","volume":"2","author":"Emerson","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.resinv.2024.07.005_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2016.05.001","article-title":"Increased prevalence of Pneumocystis jirovecii colonisation in acute pulmonary exacerbations of cystic fibrosis","volume":"73","author":"Green","year":"2016","journal-title":"J. Infect. Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib166","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/1040841X.2017.1297763","article-title":"Viruses in cystic fibrosis patients' airways","volume":"43","author":"Billard","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib167","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ppul.24750","article-title":"Respiratory viruses: what is their role in acute exacerbations in children with cystic fibrosis?","volume":"55","author":"Hizal","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.resinv.2024.07.005_bib168","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jcf.2022.04.014","article-title":"Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosis","volume":"21","author":"Sanders","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib169","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2016-209553","article-title":"Respiratory viruses in healthy infants and infants with cystic fibrosis: a prospective cohort study","volume":"73","author":"Korten","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.07.005_bib170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1513\/AnnalsATS.201310-346OC","article-title":"Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis","volume":"11","author":"Ramirez","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2024.07.005_bib171","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/irv.12353","article-title":"Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis","volume":"10","author":"Cousin","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.resinv.2024.07.005_bib172","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2013.12.003","article-title":"Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers - evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases","volume":"404","author":"Hentschel","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.resinv.2024.07.005_bib173","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1002\/hsr2.52","article-title":"Can secretory immunoglobulin A in saliva predict a change in lung infection status in patients with cystic fibrosis? A prospective pilot study","volume":"1","author":"Alanin","year":"2018","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.resinv.2024.07.005_bib174","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00430-019-00578-w","article-title":"Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients","volume":"208","author":"Mauch","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.resinv.2024.07.005_bib175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.diagmicrobio.2017.08.013","article-title":"Scedosporium boydii CatA 1 and SODC recombinant proteins, new tools for serodiagnosis of Scedosporium infection of patients with cystic fibrosis","volume":"89","author":"Mina","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.resinv.2024.07.005_bib176","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01874-22","article-title":"Specificity of immunoglobulin response to nontuberculous mycobacteria infection in people with cystic fibrosis","author":"Malcolm","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.resinv.2024.07.005_bib177","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jcf.2013.05.002","article-title":"Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis","volume":"12","author":"Paats","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082297","article-title":"A new method to improve the clinical evaluation of cystic fibrosis patients by mucus viscoelastic properties","volume":"9","author":"Tomaiuolo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib179","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jcf.2014.03.006","article-title":"Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection","volume":"13","author":"Bortoluzzi","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib180","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ppul.23225","article-title":"Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation","volume":"50","author":"Laguna","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib181","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/thoraxjnl-2014-206710","article-title":"Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry","volume":"71","author":"Quon","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.07.005_bib182","first-page":"92","article-title":"Biomarkers of inflammation and remodelling in cystic fibrosis","volume":"3","author":"Conese","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.resinv.2024.07.005_bib183","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01569-2016","article-title":"Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa","volume":"50","author":"Pattison","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib184","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01437-2016","article-title":"Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging","volume":"50","author":"Ciet","year":"2017","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.resinv.2024.07.005_bib185","first-page":"1","article-title":"Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function","volume":"7","author":"van Horck","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.07.005_bib186","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jcf.2017.11.005","article-title":"The expression of Mirc1\/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients","volume":"17","author":"Krause","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib187","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/ppul.24144","article-title":"Quantitative chest computerized tomography and FEV1 equally identify pulmonary exacerbation risk in children with cystic fibrosis","volume":"53","author":"Sanders","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib188","doi-asserted-by":"crossref","first-page":"575","DOI":"10.12688\/f1000research.13926.1","article-title":"Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations","volume":"7","author":"Quon","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib189","first-page":"144","article-title":"Early detection of cystic fibrosis acute pulmonary exacerbations by exhaled breath condensate metabolomics","author":"Zang","year":"2019","journal-title":"J Proteome Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib190","first-page":"856","article-title":"Procalcitonin predicts the severity of cystic fibrosis pulmonary exacerbations and readmissions in adult patients: a prospective cohort study","volume":"68","author":"Bailey","year":"2020","journal-title":"JIM"},{"key":"10.1016\/j.resinv.2024.07.005_bib191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173257","article-title":"Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity","volume":"12","author":"Hair","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.005_bib192","article-title":"Associations of sputum biomarkers with clinical outcomes in people with cystic fibrosis","author":"Liou","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.resinv.2024.07.005_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.739311","article-title":"miR-224-5p and miR-545-5p levels relate to exacerbations and lung function in a pilot study of X-linked MicroRNA expression in cystic fibrosis monocytes","volume":"12","author":"McKiernan","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.resinv.2024.07.005_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106687","article-title":"Sweat metabolomics before and after intravenous antibiotics for pulmonary exacerbation in people with cystic fibrosis","volume":"191","author":"Woodley","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib195","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ac522f","article-title":"Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study","volume":"16","author":"Woollam","year":"2022","journal-title":"J Breath Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib196","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/ppul.25891","article-title":"Predictive value of impulse oscillometry and multiple breath washout parameters in pediatric patients with cystic fibrosis pulmonary exacerbation","volume":"57","author":"Wojsyk-Banaszak","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2024.07.005_bib197","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiol.212641","article-title":"Use of dynamic chest radiography to assess treatment of pulmonary exacerbations in cystic fibrosis","volume":"303","author":"Simon","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2024.07.005_bib198","article-title":"Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV1 decline","volume":"48","author":"de Aquino","year":"2022","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.resinv.2024.07.005_bib199","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/abda55","article-title":"Exhaled volatile organic compounds detect pulmonary exacerbations early in children with cystic fibrosis: results of a 1 year observational pilot study","volume":"15","author":"van Horck","year":"2021","journal-title":"J Breath Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib200","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201610-2172OC","article-title":"Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations eICE study results","volume":"196","author":"Lechtzin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib201","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12890-021-01728-8","article-title":"Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation","volume":"21","author":"Hassanzad","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/RLI.0000000000000178","article-title":"Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory, and pulmonary functional parameters","volume":"50","author":"Renz","year":"2015","journal-title":"Invest Radiol"},{"key":"10.1016\/j.resinv.2024.07.005_bib203","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/acs.jproteome.6b00675","article-title":"Feasibility of early detection of cystic fibrosis acute pulmonary exacerbations by exhaled breath condensate metabolomics: a pilot study","volume":"16","author":"Zang","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1016\/j.resinv.2024.07.005_bib204","article-title":"Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease","volume":"2016","author":"Quinn","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.resinv.2024.07.005_bib205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcf.2019.09.002","article-title":"A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: results of a randomised controlled trial","volume":"19","author":"Wood","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resinv.2024.07.005_bib206","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/1357633X17723366","article-title":"High usability of a smartphone application for reporting symptoms in adults with cystic fibrosis","volume":"24","author":"Wood","year":"2018","journal-title":"J Telemed Telecare"},{"key":"10.1016\/j.resinv.2024.07.005_bib207","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00208-2021","article-title":"Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care","volume":"59","author":"Kruizinga","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.005_bib208","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thoraxjnl-2013-203807","article-title":"Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis","volume":"69","author":"Vermeulen","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.07.005_bib209","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chest.2018.03.005","article-title":"Cystic fibrosis sputum rheology correlates with both acute and longitudinal changes in lung function","volume":"154","author":"Ma","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.005_bib210","first-page":"1","article-title":"Prognosis-based early intervention strategies to resolve exacerbation and progressive lung function decline in cystic fibrosis","volume":"11","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.resinv.2024.07.005_bib211","unstructured":"Cystic Fibrosis Trust, Project Breathe, https:\/\/www.cysticfibrosis.org.uk\/what-is-cystic-fibrosis\/cystic-fibrosis-care\/personalised-healthcare\/project-breathe-app-for-remote-health-monitoring (accessed June 25, 2024)."},{"key":"10.1016\/j.resinv.2024.07.005_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1300968","article-title":"Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform","volume":"11","author":"Yaacoby-Bianu","year":"2023","journal-title":"Front Pediatr"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:58:52Z","timestamp":1732679932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524001060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":210,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2212534524001060"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.07.005","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What diagnostic tests are available for respiratory infections or pulmonary exacerbations in cystic fibrosis: A scoping literature review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}